Remedium Lifecare Enters into ₹1.83 Billion Export Order Enhances International Footprint

Image Source: india Pharma Post

India-based Remedium Lifecare Ltd has secured a multi-year export order valued at ₹1.83 billion, a major achievement in its growth strategy. The export contract with a UK-based pharmaceutical distributor places Remedium Lifecare at a prominent position in the international supply chain for APIs, intermediates, and specialty chemicals.

Contract Terms:

₹1.83 billion multi-year contract with a top UK-headquartered pharmaceutical distributor.
The transaction involves the sourcing of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals.

Market Impact:

Stock prices jumped, indicating investor faith in Remedium's international growth.
Analysts forecast a possible 100% boost in stock value on account of the transaction.

Financial Strength:

Remedium Lifecare has a zero-debt status, fortifying its financial security.
The company has a 65% promoter holding, assuring robust governance.

Strategic Growth:

Expansion to 27 nations, reinforcing its global presence.
Hyderabad-based state-of-the-art API manufacturing facilities, from being a trading company to a full-fledged manufacturer

CEO Comment:

Remedium Lifecare's top brass underscored that the transaction will drive growth and strengthen global alliances.

What's Next?

With this historic export agreement, Remedium Lifecare will be able to tap into global demand for pharma raw materials. The financial health of the company and its global reach are positives that make it a great industry player.

Sources: DNA India, Business World, Economic Times